On the products concerned
a security label is missing, which led to the assumption that they were illegally smuggled into the supply chain. The medicinal products originally imported from Italy are said to be original products and are unlikely to have been adulterated. Patients are asked to return affected medicine packs to pharmacies. The affected products were parallel imported by B&S Healthcare and then relabelled in Great Britain.
Read more in the FMD Alert of the MHRA.
MHRA: Press Release